AI in Oncology by 2030 Strategy Lab
Designing resilient cancer care systems
Shaping the Future of Oncology with AI
Why Attend?
For Clinicians and Administrators
AI in Your Clinical Setting
AI tools are arriving faster than hospitals can integrate them. For oncology teams, AI adoption means deciding when a tool is clinically mature, what evidence is sufficient, how responsibility is documented, and how the tool changes diagnosis, treatment planning, follow-up, reporting or coordination of care. For hospital administrators, it means creating the conditions for use beyond a pilot. This includes the investment case, contracting, legal and operational risk, coordination between clinical, IT and data teams, data access, staff capacity and monitoring after deployment.
Work in the Strategy Lab
Participants will identify barriers inside cancer centres, compare implementation constraints and define priority actions for clinical teams, hospital management and decision-makers. The work will focus on practical conditions for adoption, including decision rights, reliable data, usable workflows, implementation capacity and governance after deployment.
Tools to Take You Forward
Participants will return to their organisations with a basis for evaluating AI tools in oncology, covering clinical evidence, workflow impact, data requirements, accountability, compliance and post-deployment monitoring. The workshop will also identify implementation approaches that can support internal decisions with clinical committees, hospital management, IT and data teams.
Contribute to the White Paper
The working groups’ conclusions will inform a post-event white paper. Reflecting the barriers, priorities and recommendations identified by participants, the white paper will focus on the practical conditions needed for AI adoption in oncology across European cancer care systems.
For Industry Professionals
Understanding AI deployment environments
For pharmaceutical, medical technology, and digital health professionals, adoption in oncology is decided where a solution meets hospital reality. Hospitals look for clinical evidence, connection with existing systems, lawful use of health data, cybersecurity, accountability and the resources needed to maintain the solutions in practice. By 2030, companies will also need to work within the European Health Data Space (EHDS), the European Artificial Intelligence Act and stricter expectations on data governance, validation and cyber-readiness.
What Clarity Looks Like
By hearing from clinicians, hospital buyers and data regulation experts you’ll gain the big-picture insights that will reveal where your AI strategy aligns — or doesn't — with what the ecosystem will adopt. Come away with a refined understanding of what evidence is needed, what data conditions must be met, and which hospital teams need to be involved.
Contribute to the White Paper
The working groups’ conclusions will inform a post-event white paper. Reflecting the barriers, priorities and recommendations identified by participants, the white paper will focus on the practical conditions needed for AI adoption in oncology across European cancer care systems.
Four Perspectives. One Shared Vision.
About the Event
-
5 October 2026 -
EDHEC Paris Campus, 16-18 Rue du 4 septembre, 75002 Paris
The Programme
Detailed schedule coming soon!
Meet Our Scientific Committee
Pricing Details
How to get there?
Frequently asked questions
Is the event in person or online?
This is a 100% in-person event. We prioritise direct exchanges and networking to facilitate collaboration between participants, which is especially important during the small-group working sessions.
What is a "strategy lab"?
This programme is designed to go beyond high-level conference roundtables with expert-facilitated working groups on a dedicated topic. Before the event, participants will be provided a clear methodology outline for how to approach the challenge in order to best reach a quality outcome.
We feel this elevates this event above a simple workshop, enabling participants to develop a shared vision of priorities and key recommendations to make that vision real.
We feel this elevates this event above a simple workshop, enabling participants to develop a shared vision of priorities and key recommendations to make that vision real.
What are some of the participant profiles I will be working with?
Confirmed participants will be joining from the pharmaceutical industry, medical devices and innovation, clinicians, health insurance and data science.
Meet the
Innovative Health Chair Team
Strategic Pillars
- Academic and Fundamental Research
- Education and Knowledge Dissemination
- Visibility and Global Impact
